Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

BM 21.0955, a potent new bisphosphonate to inhibit bone resorption.

Mühlbauer, R.C., Bauss, F., Schenk, R., Janner, M., Bosies, E., Strein, K., Fleisch, H. · 1991 · Journal of Bone and Mineral Research

Abstract

A total of 300 new bisphosphonates were screened for their effect on bone resorption in the rat. Among these, 1-hydroxy-3-(methylpentylamino)propylidenebisphosphonate (BM 21.0955) was selected for detailed investigation. It inhibited arotinoid-stimulated bone resorption as assessed by calcemia in thyroparathyroid-ectomized rats at a SC dose as low as 0.001 mg P (0.016 μmol) per kg body weight per day. The compound was thus about 2, 10, 50, and 500 times more potent than risedronate, alendronate, pamidronate, and clodronate, respectively. Intravenous administration was as effective as subcutaneous, and oral administration was 100 times less effective. The effect after one administration decreased with time but was still measurable after 2 weeks. Nonstimulated bone resorption assayed by the urinary excretion of radiolabeled tetracycline from lifelong prelabeled animals was also inhibited. This effect started 3 days after a single dose and was still maximal after 7 days. Histomorphometric analysis of the tibial metaphysis in growing intact rats also showed an inhibition of bone resorption along with an increase in bone mass. The number of osteoclasts increased in animals treated with 0.01 and 0.1 mg P per kg (0.16 and 1.6 μmol/kg) body weight SC but decreased in animals given 1 mg P per kg (16.1 μmol/kg), showing that the inhibition of bone resorption was not due to an inhibition of osteoclast recruitment. No inhibition of mineralization occurred. This new bisphosphonate appears to have great potential for use in human bone disease.

Overview

Integrity signals

Registry

Crossref · 10.1002/jbmr.5650060915

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 30 references

Research works printed but not linked: 8

  1. Kanis, 1987, Clodronate – a new perspective in the treatment of neoplastic bone disease, Bone (Suppl.), 8, S1
  2. Burckhardt, 1989, Disodium Pamidronate (APD) in the Treatment of Malignancy-Related Disorders
  3. Charhon, 1986, Histomorphometric analysis of bone biopsies of baboons treated with “SR 41319BH,” a new diphosphonate (abstract), Calcif Tissue Int, 38, 124
  4. Bevan, 1988, Bisphosphonate action in the oophorectomized rat: The effects of 2-(3-pyridinyl)-1-hydroxyethylidene-bis(phosphonate) on skeletal metabolism; comparison with etidronate (abstract), J Bone Miner Res (Suppl.), 3, 498
  5. Valentin-Opran, 1990, Risedronate: Preliminary results of a pharmacologic study in pagetic patients. Twelfth Annual Meeting of the American Society for Bone and Mineral Research, Atlanta, Georgia, August 28–31, 1990 (abstract 182), J Bone Miner Res, 5
  6. Mühlbauer, 1990, A method for continual monitoring of bone resorption in the rat: Evidence for a diurnal rhythm, Am J Physiol, 259, R679
  7. Schenk, 1984, Methods of Calcified Tissue Preparation, 1
  8. Mühlbauer, 1989, 1-Hydroxy-3-(methylpentyl-amino)propylidene-bisphosphonate (BM 21.0955), a potent new inhibitor of bone resorption. Tenth International Conference on Calcium Regulating Hormones and Eleventh Annual Meeting of the American Society for Bone and Mineral Res, Montréal, Québec, Canada, September 9–14, 1989, J Bone Miner Res, 4

Cited by

See all 239

Metadata

Authors
Mühlbauer, R. C., Bauss, F., Schenk, R., Janner, M., Bosies, E., Strein, K., & Fleisch, H.
Affiliations
  • University of Bern (CH)
  • Boehringer Mannheim, Mannheim, Germany
Corresponding author
Mühlbauer, R.C.
Venue
Journal of Bone and Mineral Research
Published
1991-09-01
Volume
6
Issue
9
Pages
1003-1011
ISSN
  • 0884-0431 (ISSN-L)
  • 1523-4681
OpenAlex
W2012291531
Cited by
239
References
30
Citations by year
2023: 1 · 2021: 2 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 2 · 2014: 4 · 2013: 3 · 2012: 3
FWCI
4.03
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Bone and Mineral Research (publishedVersion)
  • PubMed (publishedVersion)
  • BORIS (University Library Bern) (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Bone health and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Keywords
bisphosphonates, bone resorption inhibition, osteoclasts, risedronate, alendronate, pamidronate, clodronate, bone mass, bone histomorphometry
MeSH terms
Risedronic Acid, Pamidronate, Ibandronic Acid, Animals, Benzoates, Bone Resorption, Calcium, Clodronic Acid, Diphosphonates, Injections, Intravenous, Osteoclasts, Retinoids, Etidronic Acid, Spectrophotometry, Atomic, Tetracycline, Thyroxine, Alendronate, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: BM 21.0955, a potent new bisphosphonate to inhibit bone resorption. https://app.cochat.ai/papers/10.1002/jbmr.5650060915
The paper
Mühlbauer, R. C., Bauss, F., Schenk, R., Janner, M., Bosies, E., Strein, K., & Fleisch, H. (1991). BM 21.0955, a potent new bisphosphonate to inhibit bone resorption. Journal of Bone and Mineral Research. https://doi.org/10.1002/jbmr.5650060915

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.